Pathway to ascertain the role of pharmacogenomics in healthcare utilization outcomes [response to letter]

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	545-546
Number of pages	2
Journal	Pharmacogenomics and Personalized Medicine
Volume	14
DOIs	https://doi.org/10.2147/PGPM.S316851
State	Published - 2021

ASJC Scopus subject areas

@article{402353a2316b45f19200cf3a1fe6ddfd,

title = "Pathway to ascertain the role of pharmacogenomics in healthcare utilization outcomes [response to letter]",

author = "Takahashi, {Paul Y.} and Euijung Ryu and Cerhan, {James R.} and Bielinski, {Suzette J.} and Olson, {Janet E.}",

year = "2021",

doi = "10.2147/PGPM.S316851",

language = "English (US)",

volume = "14",

pages = "545--546",

journal = "Pharmacogenomics and Personalized Medicine",

issn = "1178-7066",

publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Pathway to ascertain the role of pharmacogenomics in healthcare utilization outcomes [response to letter]

AU - Takahashi, Paul Y.

AU - Ryu, Euijung

AU - Cerhan, James R.

AU - Bielinski, Suzette J.

AU - Olson, Janet E.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85106194556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85106194556&partnerID=8YFLogxK

U2 - 10.2147/PGPM.S316851

DO - 10.2147/PGPM.S316851

M3 - Letter

AN - SCOPUS:85106194556

SN - 1178-7066

VL - 14

SP - 545

EP - 546

JO - Pharmacogenomics and Personalized Medicine

JF - Pharmacogenomics and Personalized Medicine

ER -